Prevention and Treatment of Cutaneous Leishmaniasis in Primates by Using Synthetic Type D/a Oligodeoxynucleotides Expressing CpG Motifs

Infection and Immunity - United States
doi 10.1128/iai.73.8.4948-4954.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Loopstructures in Synthetic Oligodeoxynucleotides

Nucleic Acids Research
Genetics
1980English

Treatment With LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2009English

Cooperative Stimulation of Dendritic Cells by Cryptococcus Neoformans Mannoproteins and CpG Oligodeoxynucleotides

PLoS ONE
Multidisciplinary
2008English

Cutaneous Leishmaniasis

BMJ
1990English

The Immunogenicity and Protective Efficacy of Bovine Herpesvirus 1 Glycoprotein D Plus Emulsigen Are Increased by Formulation With CpG Oligodeoxynucleotides

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2002English

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania Braziliensis in Brazil: A Randomized and Controlled Trial

PLoS Neglected Tropical Diseases
PharmacologyPublic HealthEnvironmentalToxicologyInfectious DiseasesPharmaceuticsOccupational Health
2010English

Disseminated Cutaneous Leishmaniasis in a Patient Infected by Leishmania Panamensis

American Journal of Tropical Medicine and Hygiene
MedicineVirologyParasitologyInfectious Diseases
2019English

Cutaneous Leishmaniasis in Damascus

Eastern Mediterranean Health Journal
Medicine
2009English

Cutaneous Leishmaniasis and Conflict in Syria

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy